In findings published this month in the Journal of the American Medical Association (JAMA), researchers from Stanford University indicate most people diagnosed with cancer do not receive germline genetic testing, which locates cancer gene variants that may respond more effectively to certain cancer drugs. Researchers are calling for more patients diagnosed with breast, ovarian, and certain other types of cancer to receive genetic testing to help determine the specific gene variants involved in their cases, which could improve treatment options and provide information that may lead to preventative screenings and early detection among their relatives.
